Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
720 articles
📰
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Disc Medicine, Inc. – IRON
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE – VALN
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
TELA Bio (TELA) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.Tuesday, March 24, 2026 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
📰
ACHV: 2025 Results
By John Vandermosten, CFA
NASDAQ: ACHV
READ THE FULL ACHV RESEARCH REPORT
Achieve Life Sciences, Inc. (NASDAQ: ACHV) reported 2025 results...
📰
MaxCyte (MXCT) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.Tuesday, March 24, 2026 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
📰
STRIDE Ventures Selects Eight Teams to Transform Domestic Precious Metal Recovery
NEW YORK, March 24, 2026 /PRNewswire/ -- STRIDE Ventures, operated by Start2 Group, today announced the selection of eight teams to advance to Stage...
📰
Is the Options Market Predicting a Spike in Bausch Health Stock?
Investors need to pay close attention to BHC stock based on the movements in the options market lately.
5,856 Shares in AbbVie Inc. $ABBV Acquired by Clear Trail Advisors LLC
Clear Trail Advisors LLC bought a new position in AbbVie Inc. (NYSE:ABBV – Free Report) during the 4th quarter, according to its most recent...
5,856 Shares in AbbVie Inc. $ABBV Acquired by Clear Trail Advisors LLC
Clear Trail Advisors LLC bought a new position in AbbVie Inc. (NYSE:ABBV – Free Report) during the 4th quarter, according to its most recent...
📰
ROSEN, LEADING TRIAL ATTORNEYS, Encourages PomDoctor Ltd. Investors With Losses in Excess of $100k to Secure Counsel Before Important Deadline in Securities Class Action - POM
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
BioCardia Reports 2025 Business Highlights and Financial Results
SUNNYVALE, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ:BCDA), a global leader in cellular and cell-derived therapeutics for...
📰
Biomea Fusion Reports Full Year 2025 Financial Results and Corporate Highlights
SAN CARLOS, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a...
📰
PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results
PRINCETON, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage...
📰
BioCardia Reports 2025 Business Highlights and Financial Results
SUNNYVALE, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for...
📰
TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results
MALVERN, Pa., March 24, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing...
📰
MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results
📰
Glass House Brands Reports Fourth Quarter and Full Year 2025 Financial Results
LONG BEACH, Calif and TORONTO, March 24, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U)...
📰
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Glass House Brands Reports Fourth Quarter and Full Year 2025 Financial Results
LONG BEACH, Calif and TORONTO, March 24, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U)...
📰
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Biomea Fusion Reports Full Year 2025 Financial Results and Corporate Highlights
Initiated two Phase II trials COVALENT-211 and COVALENT-212 (icovamenib in type 2 diabetes) with 26-week primary endpoint data anticipated in the...
📰
PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results
PRINCETON, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) ("PDS Biotech" or the "Company"), a late-stage...
📰
Glass House Brands Reports Fourth Quarter and Full Year 2025 Financial Results
Fourth quarter and full year results reflect temporary planned scale back in wholesale production
At year-end was back to fully planted with legacy...
📰
Glass House Brands Reports Fourth Quarter and Full Year 2025 Financial Results
Fourth quarter and full year results reflect temporary planned scale back in wholesale production
At year-end was back to fully planted with legacy...
📰
TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"...
📰
Fractyl Health Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Completed randomization in REMAIN-1 Pivotal Cohort; topline 6-Month data expected in early Q4 2026
📰
Fractyl Health Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Completed randomization in REMAIN-1 Pivotal Cohort; topline 6-Month data expected in early Q4 2026
Received favorable FDA feedback on De Novo...
📰
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Overstating Electrophysiology Growth Projections: Levi & Korsinsky
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p>NEW...
📰
Director Buys $500,000 Worth of Palvella Therapeutics Shares After Phase 3 Win
Focused on therapies for rare skin diseases, this clinical-stage biotech saw a notable director purchase coincide with a decisive Phase 3 trial...
Urgent Loans with Guaranteed Approval and No Credit Check for Bad Credit Consumers Announced by Honest Loans for 2026
Boulder, CO, March 24, 2026 (GLOBE NEWSWIRE) -- Honest Loans today announced the launch of its 2026 lending initiative, introducing expanded...
📰
Retirees: Collect a High Dividend While Diversifying Your Portfolio With This ETF
The Vanguard International High Dividend Yield ETF holds more than 1,500 stocks and yields 3.3%.
📰
Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to Know
This surgical solutions provider for nerve repair reported a notable insider sale amid a year of strong share price gains.
Move & Connect s'associe à KORE pour offrir une connectivité IdO paneuropéenne fluide aux industries critiques
ATLANTA, 24 mars 2026 /PRNewswire/ -- KORE Group Holdings, Inc. (NYSE : KORE), l'hyperscaler mondial de l'internet des objets (« IdO ») et l'un des...
6,902 Shares in UnitedHealth Group Incorporated $UNH Acquired by Clear Trail Advisors LLC
Clear Trail Advisors LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) in the fourth quarter, according to...
6,902 Shares in UnitedHealth Group Incorporated $UNH Acquired by Clear Trail Advisors LLC
Clear Trail Advisors LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) in the fourth quarter, according to...
FDA Review Puts Rezolute's Genetic Disorder Drug Path In Question
Rezolute Inc. (NASDAQ:RZLT) shares are up on Tuesday as the company is providing an update on its congenital hyperinsulinism program following a...